{
  "task_id": "task_2",
  "query": "Look for analyst ratings and sentiment analysis reports for HIMS during the last 6 months.",
  "url_sources": [
    "https://markets.businessinsider.com/news/stocks/8-analysts-assess-hims-hers-health-what-you-need-to-know-1033477423?op=1"
  ],
  "removed_matches": [],
  "cleaned_content_preview": "8 Analysts Assess Hims & Hers Health: What You Need To Know Throughout the last three months, 8 analysts have evaluated Hims & Hers Health (NYSE:HIMS), offering a diverse set of opinions from bullish to bearish. The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months. | Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish Total Ratings | 4 | 0 | 4 | 0 | 0 Last 30D | 1 | 0 | 0 | 0 | 0 1M Ago | 2 | 0 | 1 | 0 | 0 2M Ago | 0 | 0 | 3 | 0 | 0 3M Ago | 1 | 0 | 0 | 0 | 0 Analysts have recently evaluated Hims & Hers Health and provided 12-month price targets. The average target is $19.5, accompanied by a high estimate of $26.00 and a low estimate of $13.00. Observing a 16.42% increase, the current average has risen from the previous average price target of $16.75. Interpreting Analyst Ratings: A Closer Look A comprehensive examination of how financial experts perceive Hims & Hers Health is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target Michael Cherny | B of A Securities | Raises | Buy | $26.00 | $22.00 Michael Cherny | B of A Securities | Raises | Buy | $22.00 | $17.25 Maria Ripps | Canaccord Genuity | Raises | Buy | $24.00 | $20.00 Daniel Grosslight | Citigroup | Raises |..."
}